Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amides | 6 | 2023 | 66 | 3.240 |
Why?
|
| Carboxylic Ester Hydrolases | 6 | 2014 | 46 | 1.750 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 756 | 1.300 |
Why?
|
| Protein Prenylation | 3 | 2013 | 9 | 1.000 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 336 | 0.960 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 7 | 0.930 |
Why?
|
| Cell Movement | 4 | 2023 | 545 | 0.920 |
Why?
|
| Cell Proliferation | 3 | 2023 | 1149 | 0.700 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 44 | 0.670 |
Why?
|
| Cell Survival | 6 | 2021 | 818 | 0.600 |
Why?
|
| Chorioallantoic Membrane | 1 | 2016 | 10 | 0.600 |
Why?
|
| Actins | 1 | 2017 | 142 | 0.580 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 57 | 0.580 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 56 | 0.570 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 70 | 0.560 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 82 | 0.560 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 2128 | 0.520 |
Why?
|
| Neoplasms | 2 | 2023 | 1033 | 0.510 |
Why?
|
| Apoptosis | 3 | 2019 | 1317 | 0.500 |
Why?
|
| Mutation | 1 | 2019 | 1023 | 0.490 |
Why?
|
| Liver | 2 | 2008 | 447 | 0.480 |
Why?
|
| Protein Methyltransferases | 2 | 2011 | 5 | 0.470 |
Why?
|
| Curcumin | 1 | 2013 | 66 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 106 | 0.440 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2012 | 5 | 0.440 |
Why?
|
| Benzopyrans | 1 | 2012 | 10 | 0.430 |
Why?
|
| Carboxylesterase | 2 | 2011 | 4 | 0.430 |
Why?
|
| Sus scrofa | 2 | 2011 | 21 | 0.430 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1426 | 0.430 |
Why?
|
| Sulfinic Acids | 1 | 2011 | 3 | 0.410 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 396 | 0.380 |
Why?
|
| S-Adenosylmethionine | 3 | 2004 | 33 | 0.360 |
Why?
|
| Spheroids, Cellular | 2 | 2019 | 28 | 0.320 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 413 | 0.320 |
Why?
|
| Haloperidol | 2 | 2019 | 27 | 0.300 |
Why?
|
| Humans | 13 | 2023 | 34853 | 0.290 |
Why?
|
| Structure-Activity Relationship | 5 | 2019 | 376 | 0.260 |
Why?
|
| Organophosphorus Compounds | 1 | 2005 | 36 | 0.260 |
Why?
|
| Animals | 17 | 2016 | 14307 | 0.250 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2014 | 68 | 0.250 |
Why?
|
| Hydrolysis | 3 | 2011 | 86 | 0.250 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2003 | 8 | 0.240 |
Why?
|
| Cystine | 1 | 2003 | 12 | 0.240 |
Why?
|
| Kinetics | 4 | 2013 | 650 | 0.220 |
Why?
|
| Substrate Specificity | 3 | 2011 | 186 | 0.200 |
Why?
|
| Dopamine Antagonists | 3 | 2014 | 39 | 0.200 |
Why?
|
| Methylation | 4 | 2012 | 102 | 0.200 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2006 | 24 | 0.190 |
Why?
|
| Lung | 1 | 2023 | 413 | 0.190 |
Why?
|
| Receptors, sigma | 1 | 2019 | 16 | 0.170 |
Why?
|
| Azepines | 1 | 2019 | 17 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 107 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 1534 | 0.160 |
Why?
|
| Pseudopodia | 1 | 2017 | 15 | 0.150 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 30 | 0.150 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 23 | 0.150 |
Why?
|
| Pentanes | 1 | 2016 | 4 | 0.150 |
Why?
|
| Hemiterpenes | 1 | 2016 | 7 | 0.150 |
Why?
|
| Rats | 8 | 2014 | 3261 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 209 | 0.150 |
Why?
|
| Butadienes | 1 | 2016 | 30 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 44 | 0.150 |
Why?
|
| Chick Embryo | 1 | 2016 | 71 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 480 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 984 | 0.140 |
Why?
|
| Molecular Structure | 2 | 2014 | 467 | 0.140 |
Why?
|
| Polymers | 1 | 2016 | 117 | 0.140 |
Why?
|
| Protein Binding | 2 | 2017 | 913 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1442 | 0.130 |
Why?
|
| Zebrafish | 1 | 2016 | 118 | 0.130 |
Why?
|
| Cell Death | 2 | 2014 | 260 | 0.130 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2014 | 14 | 0.130 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 14 | 0.130 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 25 | 0.130 |
Why?
|
| Neurites | 1 | 2014 | 35 | 0.130 |
Why?
|
| Tropanes | 1 | 2014 | 6 | 0.130 |
Why?
|
| Acrylamides | 1 | 2014 | 8 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 13 | 0.120 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 68 | 0.120 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1993 | 1 | 0.120 |
Why?
|
| Houseflies | 1 | 1993 | 1 | 0.120 |
Why?
|
| Microtubules | 1 | 2014 | 113 | 0.120 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 48 | 0.120 |
Why?
|
| Indoles | 1 | 2014 | 154 | 0.110 |
Why?
|
| Dopamine | 4 | 2006 | 232 | 0.110 |
Why?
|
| Perfume | 1 | 2012 | 3 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2021 | 1802 | 0.110 |
Why?
|
| Brain | 3 | 2005 | 1268 | 0.110 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2011 | 3 | 0.100 |
Why?
|
| Ascaridia | 1 | 1991 | 1 | 0.100 |
Why?
|
| Ascaridiasis | 1 | 1991 | 1 | 0.100 |
Why?
|
| Biogenic Amines | 1 | 1991 | 10 | 0.100 |
Why?
|
| Poultry Diseases | 1 | 1991 | 7 | 0.100 |
Why?
|
| Swine | 1 | 2012 | 182 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2011 | 97 | 0.100 |
Why?
|
| Catalysis | 1 | 2011 | 162 | 0.100 |
Why?
|
| Neurons | 3 | 2014 | 1130 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2014 | 751 | 0.100 |
Why?
|
| Chickens | 1 | 1991 | 123 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1124 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1490 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2008 | 8 | 0.080 |
Why?
|
| Esters | 1 | 2008 | 28 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 49 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 781 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 195 | 0.080 |
Why?
|
| Cysteine | 1 | 2008 | 88 | 0.080 |
Why?
|
| Juvenile Hormones | 1 | 2006 | 3 | 0.080 |
Why?
|
| Drug Synergism | 2 | 2006 | 171 | 0.080 |
Why?
|
| Oxidopamine | 1 | 2006 | 18 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2006 | 15 | 0.070 |
Why?
|
| Cystatins | 1 | 2006 | 17 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 57 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 255 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2006 | 10 | 0.070 |
Why?
|
| Paraquat | 1 | 2006 | 20 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2006 | 52 | 0.070 |
Why?
|
| Ligands | 2 | 2019 | 317 | 0.070 |
Why?
|
| Drug Design | 1 | 2006 | 154 | 0.070 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 46 | 0.070 |
Why?
|
| Female | 2 | 2023 | 19873 | 0.060 |
Why?
|
| PC12 Cells | 3 | 2014 | 84 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 19 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2003 | 6 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 129 | 0.060 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 21 | 0.060 |
Why?
|
| Amphetamine | 1 | 2003 | 15 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2006 | 304 | 0.060 |
Why?
|
| Body Temperature | 1 | 2003 | 39 | 0.060 |
Why?
|
| Male | 7 | 2006 | 18870 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 88 | 0.060 |
Why?
|
| Triazoles | 1 | 2003 | 85 | 0.060 |
Why?
|
| Methionine | 1 | 2002 | 28 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 197 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 35 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 165 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 338 | 0.050 |
Why?
|
| California | 1 | 2023 | 436 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 358 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 874 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1993 | 406 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2014 | 103 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 70 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 537 | 0.040 |
Why?
|
| Motor Activity | 2 | 2014 | 393 | 0.040 |
Why?
|
| Cell Enlargement | 1 | 2014 | 5 | 0.030 |
Why?
|
| Catalepsy | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cerebellum | 1 | 2014 | 69 | 0.030 |
Why?
|
| Apomorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2006 | 72 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2014 | 6 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 55 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 80 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 74 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 107 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 217 | 0.030 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 1993 | 5 | 0.030 |
Why?
|
| Glycopeptides | 1 | 1993 | 11 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1991 | 37 | 0.030 |
Why?
|
| Octopamine | 1 | 1991 | 9 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1993 | 298 | 0.030 |
Why?
|
| Hippocampus | 1 | 2014 | 546 | 0.030 |
Why?
|
| Acetylation | 1 | 1991 | 94 | 0.030 |
Why?
|
| Serotonin | 1 | 1991 | 114 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 5668 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cystatin C | 1 | 2006 | 21 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2006 | 29 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 64 | 0.020 |
Why?
|
| Reproduction | 1 | 2006 | 63 | 0.020 |
Why?
|
| Lysosomes | 1 | 2006 | 80 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 13 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 194 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 423 | 0.020 |
Why?
|
| Herbicides | 1 | 2006 | 44 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2006 | 167 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 420 | 0.020 |
Why?
|
| Mazindol | 1 | 2004 | 3 | 0.020 |
Why?
|
| Tritium | 1 | 2004 | 48 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2004 | 61 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 60 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 45 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 45 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 231 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2004 | 35 | 0.020 |
Why?
|
| Benzazepines | 1 | 2004 | 29 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 92 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2004 | 134 | 0.010 |
Why?
|
| Phospholipids | 1 | 2004 | 68 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 197 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 612 | 0.010 |
Why?
|
| Benzamides | 1 | 2004 | 76 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 75 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 99 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 44 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 72 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 528 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 59 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 91 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 360 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 139 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1530 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 229 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 352 | 0.010 |
Why?
|